Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health car…
$49.52+0.28%
报价 2026-11-13
市值
$3.14B
EV
$3.08B
PE (TTM)
42.4x
预期 PE (FY2026)
36.3x
52 周区间距高点 -0.9%
$27.03$49.98
筛选结果
pipeline · 2026-11-13Filter✗ 高增长✗ Cheap✗ GARP
does not hit growth, cheap, or GARP pool
爆发潜力
2026-11-13未命中✗ 收入线✗ EPS 线
| 财年 | 收入倍数 | EPS | PE |
|---|---|---|---|
| FY+22027-12 | 1.1x | 1.28 → 1.50（1.2x） | 33.1 |
| FY+32028-12 | 1.2x | 1.28 → 1.67（1.3x） | 29.6 |
毛利率 22% · TTM 收入 $1457M · 基数 EPS 1.28（调整后）
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| GRDNGuardian Pharmacy Services, Inc. | $3.14B | +0.3% | +0.8% | 23% | 42.4x | 23.8x | 32.9x | |
| TWSTTwist Bioscience Corporation | $7.35B | -2.3% | +20.2% | 53.1% | – | – | – | |
| TXG10x Genomics, Inc. | $7.07B | -1.5% | -1.1% | 74.5% | – | 204.2x | 66.8x | |
| EWTXEdgewise Therapeutics, Inc. | $4.94B | +0.2% | – | 0% | 4.9x | 4.1x | – | |
| NHCNational HealthCare Corporation | $3.26B | -1.4% | – | – | – | – | – | |
| MDPediatrix Medical Group, Inc. | $2.45B | -0.3% | +3.4% | 27.2% | 12.6x | 9.4x | 9.5x | |
| MESOMesoblast Limited | $1.72B | +1.3% | – | 78.3% | – | – | – | |
| NUVBNuvation Bio Inc. | $1.4B | -1.7% | +245.0% | 86.6% | – | – | – | |
| PRCTPROCEPT BioRobotics Corporation | $1.37B | +1.2% | +21.1% | 66.3% | – | – | – | |
| 同行中位数 | – | – | +20.2% | 66.3% | 8.7x | 9.4x | 38.2x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
| Metric | 2026-09-30 Q3 2026 | 2026-06-30 Q2 2026 | 2026-03-31 Q1 2026 | 2025-12-31 Q4 2025 | 2025-09-30 Q3 2025 | 2025-06-30 Q2 2025 | 2025-03-31 Q1 2025 | 2024-12-31 Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $371.1M | $351.8M | $336.6M | $397.6M | $377.4M | $344.3M | $329.3M | $338.6M |
| Gross Margin | 23% | 22.8% | 22.7% | 21.5% | 19.8% | 19.8% | 19.5% | 19.8% |
| Operating Margin | 6.8% | 5.9% | 5.3% | 9.2% | 4.5% | 3.7% | 3.9% | 4.9% |
| Net Income | $18.7M | $21.9M | $13.3M | $20.9M | $9.8M | $9M | $9.4M | $11.9M |
| Diluted EPS | 0.29 | 0.34 | 0.21 | 0.33 | 0.15 | 0.14 | 0.15 | 0.2 |
| Operating Cash Flow | $43.4M | $30M | $6.1M | $34.6M | $28.2M | $19.9M | $17.6M | $22.3M |